Company news
Bluejay Diagnostics, Inc. news in 2023
Bluejay Diagnostics, Inc.'s news releases, calls and decks from 2023, newest first.
Bluejay Diagnostics Announces Pricing of $3.5 Million Public Offering
December 27, 2023
Bluejay Diagnostics, Inc. Announces Initiation of Multicenter Clinical Study Evaluating Symphony IL-6 in Sepsis Patients (SYMON Study)
December 26, 2023
Bluejay Diagnostics, Inc. Reports Third Quarter 2023 Financial Results
November 8, 2023
Bluejay Diagnostics Announces $1.59 Million Registered Direct Offering Priced At-The-Market under Nasdaq Rules
August 24, 2023
Bluejay Diagnostics Announces Clinical Update and Reports Second Quarter 2023 Financial Results
August 15, 2023
Bluejay Diagnostics Regains Compliance with Nasdaq Minimum Bid Price Requirement
August 9, 2023
Bluejay Diagnostics Updates Symphony IL-6 Regulatory Strategy
May 18, 2023
Bluejay Diagnostics Reports First Quarter 2023 Financial Results
May 9, 2023
Bluejay Diagnostics Reports 2022 Financial Results
March 19, 2023
Bluejay Diagnostics Signs Collaboration Agreement with Blood Centers of America
February 15, 2023